等待開盤 08-21 09:30:00 美东时间
-0.180
-0.26%
iRadimed (NASDAQ:IRMD) declares $0.17/share quarterly dividend, in line with previous. Forward yield 1.03% Payable Aug. 28; for shareholders of record Aug. 18; ex-div Aug. 18. See IRMD Dividend Scorec...
08-04 15:14
iRadimed shares are trading higher after the company reported better-than-expec...
08-02 01:21
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBUC) is expect...
08-01 16:32
iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on F...
08-01 02:02
Iradimed Corporation will release its 2025 second quarter financial results on August 1, 2025, followed by a conference call at 11:00 a.m. Eastern Time. Participants can register here: https://register-conf.media-server.com/register/BI52cf21ec526142b8b6142d07c87cfcf9. The call will also be available online at http://www.iradimed.com/en-us/investors/events/, with a recording accessible afterward. Iradimed is a leader in MRI-compatible medical devi...
07-25 20:05
Iradimed ( ($IRMD) ) has provided an announcement. On June 19, 2025, Iradimed C...
06-24 02:57
Iradimed Corporation has received FDA 510(k) clearance for its MRidium® 3870 IV Infusion Pump System, a next-generation MRI-compatible device. The system features a non-magnetic ultrasonic pump motor, RF non-interference, and advanced safety features, enhancing fluid delivery during MRI scans. It can operate independently or as part of a four-channel system, aiding critical care patients. The clearance strengthens Iradimed’s leadership in MRI-saf...
05-29 12:30
Iradimed Corp ( ($IRMD) ) has released its Q1 earnings. Here is a breakdown of ...
05-06 11:56
Companies Reporting Before The Bell • Recursion Pharmaceuticals (NASDAQ:RXRX) i...
05-05 16:32
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1097442598037762049.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group:维持INmune Bio(INMB)"买入"评级,目标价从22美元升至30美元</p> <p>• WestPark Capital:上调Bridgeline Digital(BLIN)评级至"买入"
02-17 15:21